Regenova 3D Bioprinting Core




Materials Characterization & Processing Core

The 3D Bioprinting facility was established in April, 2016. It is located in Room 1203 of the CMSC Building on the Johns Hopkins University's East Baltimore Campus; and houses a Cyfuse Regenova 3D Bioprinter, a scaffold-free bioprinter. The facility is overseen by Dr. Narutoshi  Hibino, Assistant Professor, Department of Cardiac Surgery <nhibino1@jhmi.edu>. It is managed by Ms. Melissa Jones <mjones91@jhmi.edu>.

Ms. Jones has been involved in the 3D printer core since its inception in January 2016; and she was involved in the design, organization, and set-up of the Regenova 3D Bioprinting in Rm 1203 CMSC when it was acquired in April 2016. Melissa has ~30 years of experience as a Research specialist and manager of the Research lab in the Division of Cardiac Surgery at the Johns Hopkins University School of Medicine. She is well versed in the use of the Regenova, tissue culture, etc; she will be the point person in charge of assisting and training new users on the Regenova printer. There is dedicated 432 square foot room for Bio-3D printer and the cell culture which includes two 6 ft laminar flow hoods, a sink, inverted microscope, centrifuge, and two incubators

Biosafety:  Our core is BL2 approved, but the printer itself, while not BL2 qualified, does not carry a  BL2 risk, as it does not have aerosol or high splash potential that increases the risk of personnel exposure. The instrument incorporates automated motion controlled by computer in a clean, isolated  bench.

Those who are interested in using the Cyfuse Regenova 3D-Bioprinter should contact Dr. Hibino at (443) 287-9193; or Ms. Jones at (410) 955-2483 or by email above.

Johns Hopkins University • Integrated Imaging Center • 3400 N. Charles Street • Dunning Hall • Baltimore, MD 21218 • Phones • Office: (410) 516-3321 • Laboratory: (410) 516-8042 • FAX: (410) 516-5213

Cyfuse Regenova 3D Bioprinter

        • Uses the Kenzan, scaffold-free method;

          • Prints with spheroids;

          • followed by bio-reacter maturation.